Stay updated on ADXS-NEO Personalized Tumor Antigens Clinical Trial
Sign up to get notified when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.
Latest updates to the ADXS-NEO Personalized Tumor Antigens Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedSeveral key resources and links related to rare diseases and clinical studies have been removed, including important government and medical websites, which may impact access to critical information.SummaryDifference3%
- Check36 days agoChange DetectedNew resources related to rare diseases and medical information have been added, including links to the NIH and Dailymed, which may be of particular interest for those researching transitional cell carcinoma and Pembrolizumab.SummaryDifference0.2%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and providing detailed participant and study information, while removing the previous version v2.12.1.SummaryDifference3%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to ADXS-NEO Personalized Tumor Antigens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.